BeStock  
Markets › Compare › GERN vs DSGN

GERN vs DSGN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
GERN · Geron$0.87 ▼ 4.63%
DSGN · Design Therapeutics$9.02 ▼ 3.22%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6899130160191Nov 24, '25May 26, '26Nov 20, '26
  • GERN -25.0%
  • DSGN +4.4%

Head to head

MetricGERNDSGN
Price$0.87$9.02
Change today▼ 4.63%▼ 3.22%
Market cap$560.94M$577.61M
Return, 3 months-42.7%-40.8%
Return, year to date-34.0%-3.8%
Return, 1 year-22.3%+8.0%
P/E (TTM)––
P/B2.52.9
P/E percentile vs own 5y18th35th
Dividend yield––
Revenue growth (YoY, latest qtr)+27.4%–
Net profit growth (YoY)+107.3%-19.4%
Gross margin91.6%–
Operating margin-7.2%–
Net margin-22.0%–
Return on equity-20.1%-36.9%
Analyst target vs. price+339.9%+140.2%
Analyst buy share75%100%
RSI (14)3633
30-day volatility94.4%68.5%
Max drawdown, 1 year-55.4%-43.4%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • DSGN is the largest of the group by market value.
  • DSGN has returned the most over the past year.
  • DSGN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top